Ultrasound imaging for the rheumatologist XLIV. Ultrasound of the shoulder in healthy individuals A. Iagnocco, E. Filippucci, G. Sakellariou, F. Ceccarelli, L. Di Geso, L. Carli, L. Riente, A. Delle Sedie, G. Valesini
Full Papers
CER5206 2013,31,2 Pg. 0172-0179
Free to view
Interleukin–21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells M. Nakou, E.D. Papadimitraki, A. Fanouriakis, G.K. Bertsias, C. Choulaki, N. Goulidaki, P. Sidiropoulos, D.T. Boumpas
CER5453 2013,31,2 Pg. 0180-0188
Free to view
The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia Y.-J. Park, S.-A. Yoo, J.-H. Lee, Y.-J. Chung, C.-S. Cho, W.-U. Kim
CER4656 2013,31,2 Pg. 0189-0194
Free to view
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies K. Sarsour, J. Greenberg, J.A. Johnston, D.R. Nelson, L.A. O`brien, C. Oddoux, H. Ostrer, A. Pearlman, G. Reed
CER4855 2013,31,2 Pg. 0195-0200
Free to view
Demographics, clinical characteristics and predictive factors for total knee or hip replacement in patients with rheumatoid arthritis in Greece P.G. Pantos, A.G. Tzioufas, D.B. Panagiotakos, P.N. Soucacos, H.M. Moutsopoulos
CER5474 2013,31,2 Pg. 0201-0206
Free to view
The low binding affinity of ADAMTS4 for citrullinated fibronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis X. Yan, L. Yin, Y. Wang, Y. Zhao, X. Chang
CER5619 2013,31,2 Pg. 0207-0212
Free to view
Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report L. Cantarini, A. Brucato, G. Simonini, M. Imazio, D. Cumetti, R. Cimaz, M.R. Bacarelli, I. Muscari, A. Vitale, O.M. Lucherini, M. Galeazzi, A. Fioravanti
CER5585 2013,31,2 Pg. 0213-0218
Free to view
Relevant incidence of cervical arthritis in patients with erosive seropositive rheumatoid arthritis even today A. Hagenow, J. Seifert, A. Zeissig, K. Conrad, A. Kleymann, M. Aringer
CER5289 2013,31,2 Pg. 0219-0224
Free to view
Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity F. Bandinelli, F. Prignano, D. Bonciani, F. Bartoli, L. Collaku, A. Candelieri, T. Lotti, M. Matucci-Cerinic
CER5426 2013,31,2 Pg. 0225-0233
Free to view
Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective S.K. Heathfield, B. Parker, L.A. Zeef, I.N. Bruce, M.Y. Alexander
CER5529 2013,31,2 Pg. 0234-0242
Free to view
Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study L. Stojanovich, M. Kontic, A. Djokovic, D. Marisavljevic, N. Ilijevski, N. Stanisavljevic, Z. Mikovic, M. Petkovic, V. Kovcin
CER5644 2013,31,2 Pg. 0243-0250
Free to view
Quantification of small joint space width, periarticular bone microstructure and erosions using high-resolution peripheral quantitative computed tomography in rheumatoid arthritis C. Barnabe, E. Szabo, L. Martin, S.K. Boyd, S.G. Barr
CER5610 2013,31,2 Pg. 0251-0255
Free to view
Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus C. Chew, P.W. Pemberton, A.-M. Husain, S. Haque, I.N. Bruce
CER5626 2013,31,2 Pg. 0256-0262
Free to view
Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account D. Huscher, C. Sengler, E. Gromnica-Ihle, S. Bischoff, T. Eidner, W. Ochs, J.G. Richter, A. Zink
CER5719 2013,31,2 Pg. 0263-0271
Free to view
The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus X. Luo, L. Zhang, M. Li, W. Zhang, X. Leng, F. Zhang, Y. Zhao, X. Zeng
CER6024 2013,31,2 Pg. 0272-0280
Free to view
Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma C. Baldini, M. Mosca, A. Della Rossa, P. Pepe, C. Notarstefano, F. Ferro, N. Luciano, R. Talarico, C. Tani, A.G. Tavoni, S. Bombardieri
Brief Papers
CER5455 2013,31,2 Pg. 0281-0284
Free to view
Ultrasound examination of symptomatic ankles in shorter-duration rheumatoid arthritis patients often reveals tenosynovitis T. Suzuki, A. Okamoto
CER5888 2013,31,2 Pg. 0285-0288
Free to view
Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study. L. Di Gioia, C. Zincarelli, M.N.D. Di Minno, G. Rengo, R. Peluso, A. Spanò, S. Iervolino, N. Pappone
Review
CER5822 2013,31,2 Pg. 0289-0294
Free to view
IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome: a Caucasian patient and literature review Q. Yao, G. Wu, A. Hoschar
CER5935 2013,31,2 Pg. 0295-0301
Free to view
Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus C.-L. Chin, R.S. Tan, J. Thumboo
Paediatric Rheumatology
CER5131 2013,31,2 Pg. 0302-0309
Free to view
Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results) T. Imagawa, R. Nishikomori, H. Takada, S. Takeshita, N. Patel, D. Kim, K. Lheritier, T. Heike, T. Hara, S. Yokota
CER5810 2013,31,2 Pg. 0310-0317
Free to view
Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever T.C. Robazzi, L.F. Adan, K. Pimentel, I. Guimarães, J. Magalhães Filho, M.B. Toralles, A.M. Rolim
Letter
CER5437 2013,31,2 Pg. 0318-0319
Free to view
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA) F. Bandinelli, F. Prignano, D. Bonciani, S. Pallanti, T. Lotti, F. Salaffi, F. Bartoli, A. Candelieri, L. Giovannini, M. Matucci-Cerinic, S. Maddali Bongi
CER5712 2013,31,2 Pg. 0320-0321
Free to view
Golimumab treatment for complicated uveitis E. Miserocchi, G. Modorati, I. Pontikaki, P. Meroni, V. Gerloni
CER5755 2013,31,2 Pg. 0322-0323
Free to view
Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results M. Benucci, M. Manfredi, G. Saviola, P. Sarzi-Puttini, F. Atzeni
CER5773 2013,31,2 Pg. 0324-0325
Free to view
Could the clinical differences between men and women with psoriatic arthritis be explained in part by genetic factors? R. Queiro, P. Tejón, P. Coto, M. Alperi, S. Alonso, C. Sarasqueta, S. González, J. Martínez-Borra, C. López-Larrea, J. Ballina
CER6007 2013,31,2 Pg. 0326-0327
Free to view
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an atypical case during treatment with sulfasalazine G. Famularo, M.C. Bravi, L. Gasbarrone, G. Minisola